Back to news

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra

Business Wire•16/11/2026•08:00 ET
0

Key Highlights

  • ➤GE HealthCare expands Photonova Spectra collaborations across seven institutions on three continents
  • ➤Photonova Spectra received CE Mark, U.S. FDA 510(k) clearance and Japan PMDA approval
  • ➤Institutions will evaluate clinical applications, quantitative imaging and diagnostic capabilities
  • ➤Stanford Medicine expands technical and human-subject studies of Photonova Spectra
  • ➤GE HealthCare is a $20.6 billion business with approximately 54,000 colleagues

Expert Statements

Chad Rowland, Executive Director, Global CT, GE HealthCare

“Deep Silicon photon-counting CT has the potential to change not only what clinicians can see, but what they can understand from every scan – creating new possibilities for early detection, personalized care and diagnostic confidence”

Chad Rowland, Executive Director, Global CT, GE HealthCare

“Realizing that potential requires close collaboration with the research and clinical community. By working alongside leading healthcare institutions around the world, we’re generating the clinical evidence and real-world experience needed to help define the future of photon-counting CT and ultimately improve care for patients.”

Gianluca Pontone, Deputy Scientific Director; Director of the Department of Perioperative Cardiology and Cardiovascular Imaging; and Co-Director of the Sport Cardiology Unit, Centro Cardiologico Monzino IRCCS

“Cardiovascular disease remains one of the world’s leading health challenges, underscoring the need for imaging technologies that enable more informed clinical decision-making”

Gianluca Pontone, Deputy Scientific Director; Director of the Department of Perioperative Cardiology and Cardiovascular Imaging; and Co-Director of the Sport Cardiology Unit, Centro Cardiologico Monzino IRCCS

“We’re excited to work alongside GE HealthCare to better understand how Photonova Spectra can generate new clinical insights and help support more personalized cardiovascular care.”

Philipp Kaufmann, Director of the Department of Nuclear Medicine, Universitätsspital Zürich

“Photon-counting CT offers exciting opportunities to advance coronary imaging by combining high spatial resolution with spectral information”

Philipp Kaufmann, Director of the Department of Nuclear Medicine, Universitätsspital Zürich

“We aim to determine how best to translate these capabilities into robust, dose-efficient CCTA protocols that support confident clinical decision-making.”

Adam Wang, Assistant Professor, Department of Radiology and, by courtesy, Electrical Engineering, Stanford University

“Our collaboration with GE HealthCare has given our researchers an opportunity to explore how photon-counting CT can be applied across a range of technical and clinical questions,””

Adam Wang, Assistant Professor, Department of Radiology and, by courtesy, Electrical Engineering, Stanford University

“We’re excited to continue our work with Photonova Spectra, building on our experience in reconstruction, image analysis and human-subject research to further investigate the capabilities of photon-counting CT and where it may create new opportunities for clinical practice and scientific discovery.”

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra

* Seven highly respected institutions across three continents will evaluate the clinical applications, quantitative imaging and diagnostic capabilities of GE HealthCare’s next-generation photon-counting CT across diverse clinical settings and care areas

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in